G01N 2333/4713
Plasma globulins, lactoglobulin
G01N2333/4713 (Plasma globulins, lactoglobulin) appears on 26 US grants and 65 published applications in this corpus.
Search patents in G01N- Granted patents
- 26
- Published applications
- 65
- Assignees
- 47
- Inventors
- 161
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 0 | 2 |
| 2012 | 1 | 3 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 3 | 2 |
| 2016 | 1 | 7 |
| 2017 | 0 | 4 |
| 2018 | 1 | 6 |
| 2019 | 1 | 1 |
| 2020 | 4 | 2 |
| 2021 | 2 | 5 |
| 2022 | 2 | 4 |
| 2023 | 1 | 5 |
| 2024 | 4 | 7 |
| 2025 | 2 | 1 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Assays for determining plasma kallikrein system biomarkers14 Oct 2025US 12,442,824 B2Takeda Pharmaceutical Company Limited
- Milking arrangement for animal health condition indication13 May 2025US 12,295,344 B2DeLaval Holding AB
- Nucleic acid aptamer specifically recognizing β-lactoglobulin and use thereof26 Nov 2024US 12,152,245 B2Jiangnan University
- Means and methods for determining risk of type-1 diabetes by serum protein biomarkers11 Jun 2024US 12,007,391 B2Turun Yliopisto
- Biomarker pairs for predicting preterm birth21 May 2024US 11,987,846 B2Sera Prognostics, Inc.
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Methods for diagnosing advanced liver fibrosis or liver cirrhosis10 Sep 2026US 2026/0266842 A1Genfit
- Biomarker for diagnosing central precocious puberty in females and uses thereof29 Jan 2026US 2026/0029418 A1Affiliated Hospital of Nantong University
- Biomarkers of fibrosis and uses therefor1 Jan 2026US 2026/0002944 A1
- Glycan structures of haptoglobin as a biomarker of hepatocellular carcinoma8 May 2025US 2025/0149180 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents
- Methods of diagnosing liver fibrosis30US 6,986,995 B2Prometheus Laboratories Inc. · 2006
- Reagents and methods useful for detecting diseases of the breast13US 6,379,671 B1Abbott Laboratories · 2002
- Reagents and methods useful for detecting diseases of the breast9US 6,552,164 B1Abbott Laboratories · 2003
- Quantitative diagnostic methods using multiple parameters7US 8,158,374 B1Ridge Diagnostics, Inc. · 2012
- Assays for determining plasma kallikrein system biomarkers6US 11,372,002 B2Takeda Pharmaceutical Company Limited · 2022